R. G. Wiewrodt (Muenster, Germany), P. Mohapatra (Chandigarh, India)
LATE-BREAKING ABSTRACT: The bedside autofluorescence pleuroscopy for the undiagnosed lung cancer with pleural effusion in a intensive care unit
H. Ooi, S. M. Chang, C. M. Liu, K. L. Chiu, J. Y. Wu, N. Y. Hsu (Tanzi District, Taichung City, Taiwan)
|  |
LATE-BREAKING ABSTRACT: Triplet chemotherapy (paclitaxel/gemcitabine/cisplatin) is more active in advanced squamous cell subtype (SCC) non-small cell lung cancer (NSCLC) than doublet treatment (vinorelbine/cisplatin): A randomized phase III trial in 443 NSCLC patients
J. B. Sorensen, A. Vilmar, H. Frank, O. Hansen (Copenhagen, Aalborg, Odense, Denmark)
|  |
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
A. Attia, M. El Sammak, M. Suleman (Dammam, Saudi Arabia)
| |
Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma
C. Tabata, T. Terada, R. Tabata, T. Nakano (Nishinimiya, Amagasaki, Japan)
| |
Diagnostic value of vascular endothelial growth factor, glycosaminoglycan, cathepsin S, cathepsin H in the discrimination of transudate exudate and benign malignant patients with pleural effusion
N. Göloglu, C. Özge, G. Polat, S. Akbayir, B. Tasdelen, E.S. Özgür, S. Atis Nayci, A. Ilvan (Mersin, Turkey)
| |
F-18 FDG PET scan 20 years after talc pleurodesis: Report of 3 cases
T. Vandemoortele, S. Laroumagne, O. Bylicki, H. Dutau, P. Astoul (Marseille, France)
| |
Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
V. Pinelli, E. Roca, S. Laroumagne, S. Lucchini, G.F. Tassi, P. Astoul (Brescia, Italy; Marseille, France)
| |
Diagnostic yield of image guided Abrams needle versus Tru-cut needle pleural biopsies for non-granulomatous pleural disease: A large tertiary centre experience
D. Jayaram, L. Ahmed, M. Prica, P. Mezes, I. Ahmed (London, United Kingdom)
| |
Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
L. Antonangelo, D. Rosolen, G. Bottura, L. Kulikowski, A. Nascimento, L. Teixeira, F. Vargas (Sao Paulo, Brazil)
| |
Ultrasound guided forceps biopsy of the pleura
Y. Ahmed, G. Agmy, L. Shahban, N. Kamel (Assiut, Egypt)
| |
How much of a role does immunohistochemistry have in reaching a final diagnosis of pleural malignancy in routine clinical practice?
K. Woolnough (Stoke-on-Trent, United Kingdom)
| |
The effect of a pleural diseases clinic on pleural effusion admission rates
S. Saikia, K. Rowe, H.E. Davies (Cardiff, United Kingdom)
| |
Incidence of lung entrapment in malignant pleural effusion
I. Bin Mohamed Noor (Singapore, Singapore)
| |
Symptoms, emergency admissions and place of death in patients with pleural malignancy
F. Christie, M. Polubothu, F. Thomson, K.G. Blyth (Glasgow, United Kingdom)
| |
Educational opportunities provided by a specialist pleural diseases clinic
M. Ahmed, J. Whittingham, H.E. Davies (Cardiff, United Kingdom)
| |
Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions?
K. Hassaan, M. Fathy (Zagazig, Egypt)
| |
Clinical characteristics, treatment and survival outcomes in malignant mesothelioma
S. Berk, O.T. Dogan, S. Kiliçkap, K. Epöztürk, I. Akkurt, Z. Seyfikli (Sivas, Turkey)
| |